Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 34341578

Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Nat Med
Publication date
2021 Sep
First author
Mai HQ

This record carries publication-notice metadata. Review the notices below before relying on it.

Publication notices

absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Med. 2021 Sep;27(9):1512-1513. doi: 10.1038/s41591-021-01482-8.
    note
    Source null
    related pmid
    34518676
    relationship
    Comment in
  2. citation
    Nat Med. 2022 Jan;28(1):214. doi: 10.1038/s41591-021-01673-3.
    note
    Source null
    related pmid
    35027760
    relationship
    Erratum in

Authors and identifiers

  1. name
    Mai HQ
    type
    Author
  2. name
    Chen QY
    type
    Author
  3. name
    Chen D
    type
    Author
  4. name
    Hu C
    type
    Author
  5. name
    Yang K
    type
    Author
  6. name
    Wen J
    type
    Author
  7. name
    Li J
    type
    Author
  8. name
    Shi YR
    type
    Author
  9. name
    Jin F
    type
    Author
  10. name
    Xu R
    type
    Author
  11. name
    Pan J
    type
    Author
  12. name
    Qu S
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Mai HQ
    type
    Author
  2. name
    Chen QY
    type
    Author
  3. name
    Chen D
    type
    Author
  4. name
    Hu C
    type
    Author
  5. name
    Yang K
    type
    Author
  6. name
    Wen J
    type
    Author
  7. name
    Li J
    type
    Author
  8. name
    Shi YR
    type
    Author
  9. name
    Jin F
    type
    Author
  10. name
    Xu R
    type
    Author
  11. name
    Pan J
    type
    Author
  12. name
    Qu S
    type
    Author
bibliography ids
  1. nci-bib-ef658ce615951c2760a720bf
book metadata
content sha256
7a628227ef7e95c65065334523bd1057b20e319deac584f2a915461b527d47ad
document type
citation
dois
  1. 10.1038/s41591-021-01444-0
electronic publication date
display
2021 Aug 2
precision
day
year
2021
evidence scope
bibliographic_metadata_only
id
pubmed:34341578
immutable id
pubmed:34341578@7a628227ef7e95c65065334523bd1057b20e319deac584f2a915461b527d47ad
journal
abbreviation
Nat Med
issn electronic
1546-170X
issn print
1078-8956
issue
9
name
Nature medicine
nlm unique id
9502015
pages
1536-1543
volume
27
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
true
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Nat Med. 2021 Sep;27(9):1512-1513. doi: 10.1038/s41591-021-01482-8.
    note
    Source null
    related pmid
    34518676
    relationship
    Comment in
  2. citation
    Nat Med. 2022 Jan;28(1):214. doi: 10.1038/s41591-021-01673-3.
    note
    Source null
    related pmid
    35027760
    relationship
    Erratum in
outcomes validated
false
pmid
34341578
provenance
batch id
192b6392c165c6b06274
provider
NCBI PubMed ESummary
record sha256
bef5a703ec5fcc6ac7712008b011fe3898341b1f87a1bd451b8206cf8978ae03
response sha256
7d81e9fb11ee99e6ad4116aecd61ba71cd6bf76f2a8f8f6d15c5c85e9c6c56b4
retrieved at
2026-09-09T23:48:02.713075+00:00
publication date
display
2021 Sep
precision
month
year
2021
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/34341578/
title
Toripalimab or placebo plus chemotherapy as first-line treatment in advanced nasopharyngeal carcinoma: a multicenter randomized phase 3 trial.

Preserved source evidence · Not medical advice